Keeping Up to Date with Ongoing Trials in Gene Therapy for Neurological Disorders
Time: 9:00 am
day: Day Two
Details:
- Overview of the current active clinical and preclinical landscape within gene therapies for neurological disorders along with key regulatory milestones
- Approval and discontinuation lifecycles
- Analysis into the disease landscape within neurological disorders, comparing rare vs non-rare disease indications
